The grades of five health care provider stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Cross Country Healthcare, Inc. (CCRN) is bettering its rating of C (“hold”) from last week to a B (“buy”) this week. In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Surprise and Sales Growth, CCRN also gets A’s. Cross Country Healthcare provides healthcare staffing and outsourcing services to the healthcare market. For more information, get Portfolio Grader’s complete analysis of CCRN stock.
The rating of Triple-S Management Corporation Class B (GTS) moves up this week, rising from an A to a C. Triple-S Management is an independent licensee of the Blue Cross Blue Shield Association. For more information, get Portfolio Grader’s complete analysis of GTS stock.
Fresenius Medical Care AG & Co. KGaA Sponsored ADR’s (FMS) ratings are looking better this week, moving up to a B from last week’s C. Fresenius Medical Care offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. For more information, get Portfolio Grader’s complete analysis of FMS stock.
Bio-Reference Laboratories, Inc. (BRLI) is progressing from last week’s rating of B (“buy”) as the company improves to an A (“strong buy”) this week. Bio-Reference provides laboratory testing services, primarily to customers in the greater New York metropolitan area. For more information, get Portfolio Grader’s complete analysis of BRLI stock.
DaVita HealthCare Partners Inc. (DVA) gets a higher grade this week, advancing from a C last week to a B. DaVita operates kidney dialysis centers in the United States. For more information, get Portfolio Grader’s complete analysis of DVA stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.